Consumer activism in the pharmacology of HIV

Rosengarten, Marsha. 2004. Consumer activism in the pharmacology of HIV. Body & Society, 10(1), pp. 91-107. ISSN 1357034X [Article]

No full text available

Abstract or Description

This article explores problems posed by HIV anti-retroviral combination therapies by focusing on the UK media promotion of Trizivir (a GlaxoSmithKline three-drugs-in-one tablet). Using the substance of the figural in the style of feminist critiques of science and borrowing from actor network theory, a synergistic relationship comprising HIV, anti-HIV drugs, drug manufacturers and their media, medical publications, consumer representative treatment information and mass media is shown to construct a worrisome set of choices. The coming together of otherwise divergent interests and media raises questions about a certain adherence to drug manufacturer ‘facts’. But more provocative is the Trizivir campaign itself. For it suggests a stridency that goes well beyond the limits of its choices and, in doing so, offers the possibility for renewed consumer activism.

Item Type:


Identification Number (DOI):


consumer activism, drug advertising, HIV anti-retroviral therapy, media

Departments, Centres and Research Units:

Sociology > Centre for Study of Invention and Social Process (CSISP) [2003-2015]


1 March 2004Published

Item ID:


Date Deposited:

12 Mar 2009 15:42

Last Modified:

07 Jul 2017 12:26

Peer Reviewed:

Yes, this version has been peer-reviewed.


Edit Record Edit Record (login required)